Evidence map›Paper›PMID 33460504›Full record

ReviewThe FEBS journal2021

More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization.

Markus Kieler, Melanie Hofmann, Gernot Schabbauer

Abstract readReview
In one paragraph

Review in The FEBS journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Kynurenine-AhR-SLC39A10-ZnCell communication and signaling : CCS · 2026
    Article
  16. Review
  17. Article
  18. Ganoderic Acid a Promotes Functional Recovery After Traumatic Brain Injury By Protecting Blood-brain Barrier Integrity and Modulating Microglial Polarization.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  19. Review
  20. Review

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Markus KielerInstitute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-4082-5731
Melanie HofmannInstitute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-0835-4183
Gernot SchabbauerInstitute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-7490-8009

Funding

Austrian Science Fund FWF P 30026
6 · The paper itself

Abstract

Macrophages represent the first line of defence in innate immune responses and additionally serve important functions for the regulation of host inflammation and tissue homeostasis. The M1/M2 model describes the two extremes of macrophage polarization states, which can be induced by multiple stimuli, most notably by LPS/IFN-γ and IL-4/IL-13. Historically, the expression of two genes encoding for enzymes, which use the same amino acid as their substrate, iNOS and ARG1, has been used to define classically activated M1 (iNOS) and alternatively activated M2 (ARG1) macrophages. This 'arginine dichotomy' has recently become a matter of debate; however, in parallel with the emerging field of immunometabolism there is accumulating evidence that these two enzymes and their related metabolites are fundamentally involved in the intrinsic regulation of macrophage polarization and function. The aim of this review is to highlight recent advances in macrophage biology and immunometabolism with a specific focus on amino acid metabolism and their related metabolic pathways: iNOS/ARG1 (arginine), TCA cycle and OXPHOS (glutamine) as well as the one-carbon metabolism (serine, glycine).

Indexed as

ArginaseArginineCell DifferentiationCitric Acid CycleGene Expression RegulationGlutamineGlycineHumansImmunity, InnateInterferon-gammaLipopolysaccharidesMacrophage ActivationMacrophagesMitochondriaNitric OxideNitric Oxide Synthase Type IIARG1 protein, humanArginaseArginineGlutamineGlycineInterferon-gammaLipopolysaccharidesNitric OxideNitric Oxide Synthase Type IINOS2 protein, humanSerinearginase/iNOSglutamineimmunometabolismmacrophage polarizationnitric oxideoxidative phosphorylationpolyaminesserineTCA cycleα-ketoglutarate

Identifiers

PMID33460504
PMCPMC8359336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.